首页 > 最新文献

The Lancet regional health. Southeast Asia最新文献

英文 中文
Mobilizing students to effect multidisciplinary cancer care: the Tumor Board Establishment Facilitation Forum 动员学生开展多学科癌症治疗:肿瘤委员会成立促进论坛
IF 5 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-06-24 DOI: 10.1016/j.lansea.2024.100441
Muhammad Abdul Rehman , Urooba Jawwad , Erfa Tahir , Unaiza Naeem , Maheen Qamar , Nowal Hussain , Nimrata Kumari , Ahmed Nadeem Abbasi , Agha Muhammad Hammad Khan
{"title":"Mobilizing students to effect multidisciplinary cancer care: the Tumor Board Establishment Facilitation Forum","authors":"Muhammad Abdul Rehman , Urooba Jawwad , Erfa Tahir , Unaiza Naeem , Maheen Qamar , Nowal Hussain , Nimrata Kumari , Ahmed Nadeem Abbasi , Agha Muhammad Hammad Khan","doi":"10.1016/j.lansea.2024.100441","DOIUrl":"https://doi.org/10.1016/j.lansea.2024.100441","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":5.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277236822400091X/pdfft?md5=592d6ef4269712daff4af8306b8b34f7&pid=1-s2.0-S277236822400091X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141479024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CFTR mutations and phenotypic correlations in people with cystic fibrosis: a retrospective study from a single centre in south India 囊性纤维化患者的 CFTR 基因突变和表型相关性:印度南部一个中心的回顾性研究
Pub Date : 2024-06-11 DOI: 10.1016/j.lansea.2024.100434
Sneha D. Varkki , Rekha Aaron , Aaron Chapla , Sumita Danda , Priyanka Medhi , N. Jansi Rani , Grace R. Paul

Background

Emerging data reveal higher-than-expected prevalence of cystic fibrosis (CF) among non-European populations worldwide including in the Indian subcontinent. Systematic analyses of the CFTR mutation profile, and genotype-phenotype correlations among people with CF from south, east, or northeast India have not been reported before. We wanted to identify CFTR mutations in people with CF, and highlight novel variants, selective phenotypic correlations, and regional variances within India.

Methods

A retrospective study was conducted at Christian Medical College, Vellore, India (single tertiary referral hospital) from September 2010 to August 2022, involving 120 people with CF from (i) four south Indian states (Tamil Nadu, Andhra Pradesh, Kerala, Karnataka), (ii) in and nearby regions of West Bengal, India and (iii) Bangladesh. Comprehensive CFTR mutation analyses were done by Next-Generation Sequencing, and variants were categorized per American College of Medical Genetics guidelines and compared with validated Locus-specific databases. Demographic characteristics, mutation profile, novel mutations, selective phenotype correlations, and regional variances were assessed.

Findings

In 120 people with CF, 55 CFTR variants were identified, including six novel variants. F508del was the predominant mutation, yet with a lower allele frequency than reported among European populations (27% versus 70%). Phenotypic correlations suggested high mutational pathogenicity causing severe multi-organ morbidity, and death in 27%. Milder variants associated with pancreatic sufficiency were also evident in 23% of people with CF. Statistically significant regional variances were noted in genotype frequency, and clinical phenotype among people with CF from the two regions. Hotspot exons and introns that could potentially help create targeted mutation panels were identified.

Interpretation

The identification of 55 different CFTR variants among 120 people with CF describes the diversity of mutations noted in India, while also revealing the challenges that providers may encounter in timely diagnosis and treatment of CF. However, these single-centre data have specific limitations and cannot be generalised to all people with CF from India or to those of non-European origin. Our data on regional CFTR mutations contribute to the emerging national registry on CF epidemiology in India, help formulate diagnostic and newborn screening algorithms, help optimise clinical care, and highlight urgency to improve access to life-changing modulator therapy.

Funding

Cystic Fibrosis Foundation, USA (towards the CF-India Demonstration Project) and Christian Medical College, Vellore, India.

背景最新数据显示,囊性纤维化(CF)在包括印度次大陆在内的全球非欧洲人群中的发病率高于预期。对印度南部、东部或东北部 CF 患者的 CFTR 基因突变情况以及基因型与表型之间的相关性进行系统分析的研究以前从未报道过。2010年9月至2022年8月,我们在印度韦洛尔基督教医学院(单一三级转诊医院)开展了一项回顾性研究,涉及120名CF患者,他们分别来自(i)印度南部四个邦(泰米尔纳德邦、安得拉邦、喀拉拉邦、卡纳塔克邦),(ii)印度西孟加拉邦及其附近地区,以及(iii)孟加拉国。通过新一代测序技术对 CFTR 基因突变进行了全面分析,并根据美国医学遗传学会的指导原则对变异进行了分类,同时与经过验证的特定病灶数据库进行了比较。对人口统计学特征、变异概况、新型变异、选择性表型相关性和地区差异进行了评估。研究结果在 120 名 CF 患者中发现了 55 个 CFTR 变异,其中包括 6 个新型变异。F508del是最主要的变异,但等位基因频率低于欧洲人群(27%对70%)。表型相关性表明变异的致病性很高,会导致严重的多器官发病,27%的患者会死亡。在23%的CF患者中,与胰腺功能不足有关的较轻变异也很明显。据统计,这两个地区的CF患者在基因型频率和临床表型方面存在明显的地区差异。在 120 名 CF 患者中鉴定出 55 种不同的 CFTR 变异描述了印度突变的多样性,同时也揭示了提供者在及时诊断和治疗 CF 方面可能遇到的挑战。然而,这些单中心数据有其特定的局限性,不能推广到所有印度或非欧洲血统的CF患者。我们关于地区性CFTR突变的数据有助于印度CF流行病学的国家登记,有助于制定诊断和新生儿筛查算法,有助于优化临床护理,并突出了改善获得改变生命的调节剂治疗的紧迫性。
{"title":"CFTR mutations and phenotypic correlations in people with cystic fibrosis: a retrospective study from a single centre in south India","authors":"Sneha D. Varkki ,&nbsp;Rekha Aaron ,&nbsp;Aaron Chapla ,&nbsp;Sumita Danda ,&nbsp;Priyanka Medhi ,&nbsp;N. Jansi Rani ,&nbsp;Grace R. Paul","doi":"10.1016/j.lansea.2024.100434","DOIUrl":"https://doi.org/10.1016/j.lansea.2024.100434","url":null,"abstract":"<div><h3>Background</h3><p>Emerging data reveal higher-than-expected prevalence of cystic fibrosis (CF) among non-European populations worldwide including in the Indian subcontinent. Systematic analyses of the <em>CFTR</em> mutation profile, and genotype-phenotype correlations among people with CF from south, east, or northeast India have not been reported before. We wanted to identify <em>CFTR</em> mutations in people with CF, and highlight novel variants, selective phenotypic correlations, and regional variances within India.</p></div><div><h3>Methods</h3><p>A retrospective study was conducted at Christian Medical College, Vellore, India (single tertiary referral hospital) from September 2010 to August 2022, involving 120 people with CF from (i) four south Indian states (Tamil Nadu, Andhra Pradesh, Kerala, Karnataka), (ii) in and nearby regions of West Bengal, India and (iii) Bangladesh. Comprehensive <em>CFTR</em> mutation analyses were done by Next-Generation Sequencing, and variants were categorized per American College of Medical Genetics guidelines and compared with validated Locus-specific databases. Demographic characteristics, mutation profile, novel mutations, selective phenotype correlations, and regional variances were assessed.</p></div><div><h3>Findings</h3><p>In 120 people with CF, 55 CFTR variants were identified, including six novel variants. F508del was the predominant mutation, yet with a lower allele frequency than reported among European populations (27% versus 70%). Phenotypic correlations suggested high mutational pathogenicity causing severe multi-organ morbidity, and death in 27%. Milder variants associated with pancreatic sufficiency were also evident in 23% of people with CF. Statistically significant regional variances were noted in genotype frequency, and clinical phenotype among people with CF from the two regions. Hotspot exons and introns that could potentially help create targeted mutation panels were identified.</p></div><div><h3>Interpretation</h3><p>The identification of 55 different <em>CFTR</em> variants among 120 people with CF describes the diversity of mutations noted in India, while also revealing the challenges that providers may encounter in timely diagnosis and treatment of CF. However, these single-centre data have specific limitations and cannot be generalised to all people with CF from India or to those of non-European origin. Our data on regional <em>CFTR</em> mutations contribute to the emerging national registry on CF epidemiology in India, help formulate diagnostic and newborn screening algorithms, help optimise clinical care, and highlight urgency to improve access to life-changing modulator therapy.</p></div><div><h3>Funding</h3><p><span>Cystic Fibrosis Foundation</span>, USA (towards the CF-India Demonstration Project) and <span>Christian Medical College, Vellore</span>, India.</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368224000842/pdfft?md5=23612e6a8864e73a581dd95e0167b0fd&pid=1-s2.0-S2772368224000842-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141303221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health transition and eye care policy planning for people with diabetic retinopathy in south Asia 南亚糖尿病视网膜病变患者的健康过渡和眼科护理政策规划
Pub Date : 2024-06-11 DOI: 10.1016/j.lansea.2024.100435
Taraprasad Das , Khaleda Islam , Phuntsho Dorji , Raja Narayanan , Padmaja K. Rani , Brijesh Takkar , Raba Thapa , Muhammad Moin , Prabhath N. Piyasena , Sobha Sivaprasad

The prevalence of type 2 diabetes (T2D), associated systemic disorders, diabetic retinopathy (DR) and current health policies in south Asian countries were analysed to assess country-specific preparedness to meet the 2030 Sustainable Development Goals. The south Asian countries were classified by human development index, socio-demographic index, multidimensional poverty indices, and eye health resources for epidemiological resource-level analysis. In south Asia, the prevalence of diagnosed and undiagnosed T2D in adults aged 40 years or above, was higher in Pakistan (26.3%) and Afghanistan (71.4%), respectively; India has the highest absolute number of people with DR, and Afghanistan has the highest prevalence of DR (50.6%). In this region, out-of-pocket spending is high (∼77%). This Health Policy is a situational analysis of data available on the prevalence of DR and common eye diseases in people with T2D in south Asia and available resources to suggest tailored health policies to local needs. The common issues in the region are insufficient human resources for eye health, unequal distribution of available workforce, and inadequate infrastructure. Addressing these challenges of individuals with T2D and DR, a 10-point strategy is suggested to improve infrastructure, augment human resources, reduce out-of-pocket spending, employ targeted screening, and encourage public-private partnerships.

对南亚国家的 2 型糖尿病(T2D)发病率、相关系统性疾病、糖尿病视网膜病变(DR)和现行卫生政策进行了分析,以评估各国为实现 2030 年可持续发展目标所做的准备。南亚国家按人类发展指数、社会人口指数、多维贫困指数和眼健康资源进行分类,以进行流行病学资源层面的分析。在南亚,巴基斯坦(26.3%)和阿富汗(71.4%)40 岁或以上成年人中已确诊和未确诊的 T2D 患病率分别较高;印度的 DR 患者绝对数量最多,阿富汗的 DR 患病率最高(50.6%)。在该地区,自费支出很高(∼77%)。本《卫生政策》对南亚地区慢性阻塞性肺病和 T2D 患者常见眼病的发病率数据以及可用资源进行了现状分析,以提出符合当地需求的卫生政策建议。该地区的共同问题是眼保健人力资源不足、现有劳动力分布不均以及基础设施不足。针对患有 T2D 和 DR 的个人所面临的这些挑战,提出了一项 10 点战略,以改善基础设施、增加人力资源、减少自费支出、采用有针对性的筛查以及鼓励公私合作伙伴关系。
{"title":"Health transition and eye care policy planning for people with diabetic retinopathy in south Asia","authors":"Taraprasad Das ,&nbsp;Khaleda Islam ,&nbsp;Phuntsho Dorji ,&nbsp;Raja Narayanan ,&nbsp;Padmaja K. Rani ,&nbsp;Brijesh Takkar ,&nbsp;Raba Thapa ,&nbsp;Muhammad Moin ,&nbsp;Prabhath N. Piyasena ,&nbsp;Sobha Sivaprasad","doi":"10.1016/j.lansea.2024.100435","DOIUrl":"https://doi.org/10.1016/j.lansea.2024.100435","url":null,"abstract":"<div><p>The prevalence of type 2 diabetes (T2D), associated systemic disorders, diabetic retinopathy (DR) and current health policies in south Asian countries were analysed to assess country-specific preparedness to meet the 2030 Sustainable Development Goals. The south Asian countries were classified by human development index, socio-demographic index, multidimensional poverty indices, and eye health resources for epidemiological resource-level analysis. In south Asia, the prevalence of diagnosed and undiagnosed T2D in adults aged 40 years or above, was higher in Pakistan (26.3%) and Afghanistan (71.4%), respectively; India has the highest absolute number of people with DR, and Afghanistan has the highest prevalence of DR (50.6%). In this region, out-of-pocket spending is high (∼77%). This Health Policy is a situational analysis of data available on the prevalence of DR and common eye diseases in people with T2D in south Asia and available resources to suggest tailored health policies to local needs. The common issues in the region are insufficient human resources for eye health, unequal distribution of available workforce, and inadequate infrastructure. Addressing these challenges of individuals with T2D and DR, a 10-point strategy is suggested to improve infrastructure, augment human resources, reduce out-of-pocket spending, employ targeted screening, and encourage public-private partnerships.</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368224000854/pdfft?md5=9435b39f6bf9622a28cf97490c00aeda&pid=1-s2.0-S2772368224000854-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141303222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the potential of telemedicine for improved primary healthcare in India: a comprehensive review 探索远程医疗在改善印度初级保健方面的潜力:全面综述
Pub Date : 2024-06-08 DOI: 10.1016/j.lansea.2024.100431
Ashwaghosha Parthasarathi , Tina George , Muruga Bharathy Kalimuth , Sudhindra Jayasimha , Mohammed Kaleem Ullah , Rutuja Patil , Ajay Nair , Urvi Pai , Esther Inbarani , Anil G. Jacob , V.J. Chandy , Oommen John , Thambu David Sudarsanam , Padukudru Anand Mahesh

Telemedicine is a promising solution to the challenges of delivering equitable and quality primary healthcare, especially in LMICs. This review evaluated peer-reviewed literature on telehealth interventions in Indian primary care published from Jan 1, 2011 to Dec 31, 2021, from PubMed, Scopus, TRIP, Google Scholar, Indian Kanoon, and Cochrane database The majority of Indian studies focus on key health issues like maternal and child health, mental health, diabetes, infectious diseases, and hypertension, mainly through patient education, monitoring, and diagnostics. Yet, there’s a lack of research on telemedicine’s cost-effectiveness, communication among providers, and the role of leadership in its quality and accessibility. The current research has gaps, including small sample sizes and inconsistent methodologies, which hamper the evaluation of telemedicine’s effectiveness. India's varied healthcare landscape, technological limitations, and social factors further challenge telemedicine's adoption. Despite regulatory efforts, issues like the digital divide and data privacy persist. Addressing these challenges with a context-aware, technologically driven approach is crucial for enhancing healthcare through telemedicine in India.

远程医疗是应对提供公平、优质的初级医疗服务挑战的一个前景广阔的解决方案,尤其是在低收入和中等收入国家。本综述评估了 2011 年 1 月 1 日至 2021 年 12 月 31 日期间发表的有关印度初级医疗中远程医疗干预措施的同行评议文献,这些文献来自 PubMed、Scopus、TRIP、Google Scholar、Indian Kanoon 和 Cochrane 数据库。印度的大多数研究主要通过患者教育、监测和诊断,关注母婴健康、心理健康、糖尿病、传染病和高血压等关键健康问题。然而,关于远程医疗的成本效益、医疗服务提供者之间的沟通以及领导力在其质量和可及性方面的作用的研究还很缺乏。目前的研究还存在差距,包括样本量小和方法不一致,这些都阻碍了对远程医疗有效性的评估。印度多样的医疗环境、技术限制和社会因素进一步挑战了远程医疗的应用。尽管在监管方面做出了努力,但数字鸿沟和数据隐私等问题依然存在。要想通过远程医疗加强印度的医疗保健,关键是要采用具有背景意识、技术驱动的方法来应对这些挑战。
{"title":"Exploring the potential of telemedicine for improved primary healthcare in India: a comprehensive review","authors":"Ashwaghosha Parthasarathi ,&nbsp;Tina George ,&nbsp;Muruga Bharathy Kalimuth ,&nbsp;Sudhindra Jayasimha ,&nbsp;Mohammed Kaleem Ullah ,&nbsp;Rutuja Patil ,&nbsp;Ajay Nair ,&nbsp;Urvi Pai ,&nbsp;Esther Inbarani ,&nbsp;Anil G. Jacob ,&nbsp;V.J. Chandy ,&nbsp;Oommen John ,&nbsp;Thambu David Sudarsanam ,&nbsp;Padukudru Anand Mahesh","doi":"10.1016/j.lansea.2024.100431","DOIUrl":"https://doi.org/10.1016/j.lansea.2024.100431","url":null,"abstract":"<div><p>Telemedicine is a promising solution to the challenges of delivering equitable and quality primary healthcare, especially in LMICs. This review evaluated peer-reviewed literature on telehealth interventions in Indian primary care published from Jan 1, 2011 to Dec 31, 2021, from PubMed, Scopus, TRIP, Google Scholar, Indian Kanoon, and Cochrane database The majority of Indian studies focus on key health issues like maternal and child health, mental health, diabetes, infectious diseases, and hypertension, mainly through patient education, monitoring, and diagnostics. Yet, there’s a lack of research on telemedicine’s cost-effectiveness, communication among providers, and the role of leadership in its quality and accessibility. The current research has gaps, including small sample sizes and inconsistent methodologies, which hamper the evaluation of telemedicine’s effectiveness. India's varied healthcare landscape, technological limitations, and social factors further challenge telemedicine's adoption. Despite regulatory efforts, issues like the digital divide and data privacy persist. Addressing these challenges with a context-aware, technologically driven approach is crucial for enhancing healthcare through telemedicine in India.</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368224000817/pdfft?md5=ba89c93e4afa5cdb546824b7af9f9035&pid=1-s2.0-S2772368224000817-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141291631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Household food insecurity, dietary diversity with undernutrition among children younger than five years in Indian subcontinent–a narrative review 印度次大陆五岁以下儿童的家庭粮食不安全、膳食多样性与营养不良--叙述性综述
Pub Date : 2024-06-07 DOI: 10.1016/j.lansea.2024.100426
Surabhi Singh Yadav, Hema Matela, Pooja Panchal, Kavitha Menon

The emerging predictors of childhood undernutrition include household food insecurity (HFI) and inadequate diet diversity (DD). Geographical, socio-cultural, economic, and demographic factors contribute to HFI. Earlier, HFI was often considered an outcome of hunger and poverty leading to undernutrition. The increasing availability of data related to childhood DD and its direct association with undernutrition indicates that DD could mediate the relationship between HFI and undernutrition. This narrative review examined the association of HFI and/or DD with undernutrition in children younger than 5 years in the Indian subcontinent; and the current programmes and policies. The current evidence showed a possible association between HFI and DD either independently or together with childhood undernutrition. Until now, nutrition-specific interventions to address moderate and severe forms of undernutrition were focused, with a limited attention on nutrition-sensitive approaches to improve HFI and DD. Interventions which improve HFI and DD may be included in the existing programmes and would help address the undernutrition in children younger than 5 years.

儿童营养不良的新预测因素包括家庭粮食不安全(HFI)和饮食多样性不足(DD)。地理、社会文化、经济和人口因素是造成 HFI 的原因。早先,HFI 通常被认为是饥饿和贫困导致营养不良的结果。与儿童营养不良及其与营养不良的直接关系相关的数据越来越多,这表明营养不良可能介导 HFI 与营养不良之间的关系。本叙述性综述研究了印度次大陆 5 岁以下儿童的 HFI 和/或 DD 与营养不良的关系,以及当前的计划和政策。目前的证据显示,HFI 和 DD 可能单独或同时与儿童营养不良有关。迄今为止,针对中度和重度营养不良的营养干预措施一直是重点,而对改善 HFI 和 DD 的营养敏感方法关注有限。可将改善 HFI 和 DD 的干预措施纳入现有计划,这将有助于解决 5 岁以下儿童的营养不良问题。
{"title":"Household food insecurity, dietary diversity with undernutrition among children younger than five years in Indian subcontinent–a narrative review","authors":"Surabhi Singh Yadav,&nbsp;Hema Matela,&nbsp;Pooja Panchal,&nbsp;Kavitha Menon","doi":"10.1016/j.lansea.2024.100426","DOIUrl":"https://doi.org/10.1016/j.lansea.2024.100426","url":null,"abstract":"<div><p>The emerging predictors of childhood undernutrition include household food insecurity (HFI) and inadequate diet diversity (DD). Geographical, socio-cultural, economic, and demographic factors contribute to HFI. Earlier, HFI was often considered an outcome of hunger and poverty leading to undernutrition. The increasing availability of data related to childhood DD and its direct association with undernutrition indicates that DD could mediate the relationship between HFI and undernutrition. This narrative review examined the association of HFI and/or DD with undernutrition in children younger than 5 years in the Indian subcontinent; and the current programmes and policies. The current evidence showed a possible association between HFI and DD either independently or together with childhood undernutrition. Until now, nutrition-specific interventions to address moderate and severe forms of undernutrition were focused, with a limited attention on nutrition-sensitive approaches to improve HFI and DD. Interventions which improve HFI and DD may be included in the existing programmes and would help address the undernutrition in children younger than 5 years.</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368224000763/pdfft?md5=22a187d8d673c8e4d30feddd4c663402&pid=1-s2.0-S2772368224000763-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141292022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of maternal care in the Southeast Asia region 东南亚地区孕产妇保健的质量
Pub Date : 2024-06-01 DOI: 10.1016/j.lansea.2024.100433
The Lancet Regional Health – Southeast Asia
{"title":"Quality of maternal care in the Southeast Asia region","authors":"The Lancet Regional Health – Southeast Asia","doi":"10.1016/j.lansea.2024.100433","DOIUrl":"https://doi.org/10.1016/j.lansea.2024.100433","url":null,"abstract":"","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368224000830/pdfft?md5=34a250ffb7f8b99a51af96454ede5f95&pid=1-s2.0-S2772368224000830-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141429021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of low-cost kitchen with improved cookstove on birthweight of neonates in Shahjadpur, Bangladesh: a cluster-randomised controlled trial 孟加拉国 Shahjadpur 采用改良炉灶的低成本厨房对新生儿出生体重的影响:分组随机对照试验
Pub Date : 2024-06-01 DOI: 10.1016/j.lansea.2023.100342
Anisuddin Ahmed , Ahmed Ehsanur Rahman , Saifuddin Ahmed , Fariya Rahman , Hasan Mahmud Sujan , Faisal Ahmmed , Aniqa Tasnim Hossain , Abu Sayeed , Shahed Hossain , Nafisa Lira Huq , Mohammad Abdul Quaiyum , Laura Reichenbach , Shams El Arifeen

Background

Smoke from biomass fuels used for cooking in traditional cookstoves contains a variety of health-damaging pollutants. Inhalation of these pollutants by pregnant women has been linked to abnormal foetal development and adverse pregnancy outcomes, including low birthweight (LBW). There is a dearth of data on environmental interventions that have the potential to reduce exposure to biomass fuel during pregnancy and improve birth outcomes. International Centre for Diarrheal Disease Research, Bangladesh (icddr,b) therefore, designed a low-cost kitchen with an improved cookstove and examined the impact of this intervention on the birthweight of neonates.

Methods

icddr,b conducted a cluster-randomised controlled trial of a ‘low-cost kitchen with improved cookstove’ intervention among 1,267 pregnant women who used traditional cookstoves in a rural sub-district of Bangladesh. All participants were enrolled during the first trimester of pregnancy among 104 randomly selected clusters after obtaining informed consent. The model kitchens were installed in 628 participants' households of the intervention group, and 639 participants continued to use traditional cookstoves as the control group. The primary outcome was the proportion of LBW neonates between the intervention and control groups. The study also examined if the intervention would reduce CO exposure, measured by the differences in maternal blood carbon monoxide saturation (SpCO) levels and prevalence of LBW in neonates. We performed a generalized structural equation model for jointly assessing the simultaneous relationships of biomass fuel exposure to LBW of neonates and the relationships of LBW of neonates to maternal blood SpCO level. This trial was registered with ClinicalTrials.gov (NCT02923882).

Findings

We found that in the intervention group using ‘low-cost kitchen with improved cookstove’, the risk of LBW reduced by 37% (adjusted risk ratio: 0.63, 95% CI [0.45, 0.89]). Between the second and third trimester, the mean maternal blood SpCO level was significantly reduced from 10.4% to 8.9% (p-value <0.01) in the intervention group but remained unchanged in the control group (11.6% and 11.5%). Of the total effects of the intervention on the risk of LBW, 48.3% was mediated through maternal blood SpCO level.

Interpretation

The risk of LBW among rural neonates was reduced in the intervention group using ‘low-cost kitchen with improved cookstove’, which may be attributed to the reduction in maternal blood SpCO level. Additional research is needed to identify other mechanisms through which biomass fuel exposure might lead to adverse pregnancy outcomes.

Funding

Grand Challenges Canada: Rising Stars in Global Health Programme.

背景传统炉灶中用于烹饪的生物质燃料产生的烟雾含有多种损害健康的污染物。孕妇吸入这些污染物与胎儿发育异常和不良妊娠结局(包括出生体重不足)有关。目前还缺乏有关环境干预措施的数据,而这些措施有可能减少孕妇在怀孕期间接触生物质燃料的机会,并改善出生结果。因此,孟加拉国国际腹泻病研究中心(icddr,b)设计了一种带改良炉灶的低成本厨房,并研究了该干预措施对新生儿出生体重的影响。方法icddr,b在孟加拉国一个农村分区的 1267 名使用传统炉灶的孕妇中开展了一项 "带改良炉灶的低成本厨房 "干预措施的分组随机对照试验。所有参与者都是在获得知情同意后,于怀孕前三个月在随机抽取的 104 个群组中进行登记的。干预组中有 628 人的家庭安装了示范厨房,对照组中有 639 人继续使用传统炉灶。主要结果是干预组和对照组之间低体重新生儿的比例。该研究还考察了干预措施是否会减少一氧化碳暴露,衡量标准是产妇血液中一氧化碳饱和度(SpCO)水平的差异和新生儿低体重率。我们建立了一个广义结构方程模型,以共同评估生物质燃料暴露与新生儿低体重率的同步关系,以及新生儿低体重率与产妇血液中一氧化碳饱和度(SpCO)水平的关系。结果我们发现,在使用 "改良炉灶的低成本厨房 "的干预组中,枸杞体重不足的风险降低了 37%(调整风险比:0.63,95% CI [0.45,0.89])。在怀孕的第二个和第三个三个月期间,干预组产妇的平均血 SpCO 水平从 10.4% 显著降至 8.9%(p 值为 0.01),而对照组则保持不变(分别为 11.6% 和 11.5%)。在干预对低出生体重儿风险的总影响中,48.3%是通过产妇血液中的 SpCO 水平来调节的。解释使用 "改良炉灶的低成本厨房 "的干预组降低了农村新生儿的低出生体重儿风险,这可能归因于产妇血液中 SpCO 水平的降低。还需要开展更多研究,以确定接触生物质燃料可能导致不良妊娠结局的其他机制:全球健康新星计划。
{"title":"Effect of low-cost kitchen with improved cookstove on birthweight of neonates in Shahjadpur, Bangladesh: a cluster-randomised controlled trial","authors":"Anisuddin Ahmed ,&nbsp;Ahmed Ehsanur Rahman ,&nbsp;Saifuddin Ahmed ,&nbsp;Fariya Rahman ,&nbsp;Hasan Mahmud Sujan ,&nbsp;Faisal Ahmmed ,&nbsp;Aniqa Tasnim Hossain ,&nbsp;Abu Sayeed ,&nbsp;Shahed Hossain ,&nbsp;Nafisa Lira Huq ,&nbsp;Mohammad Abdul Quaiyum ,&nbsp;Laura Reichenbach ,&nbsp;Shams El Arifeen","doi":"10.1016/j.lansea.2023.100342","DOIUrl":"10.1016/j.lansea.2023.100342","url":null,"abstract":"<div><h3>Background</h3><p>Smoke from biomass fuels used for cooking in traditional cookstoves contains a variety of health-damaging pollutants. Inhalation of these pollutants by pregnant women has been linked to abnormal foetal development and adverse pregnancy outcomes, including low birthweight (LBW). There is a dearth of data on environmental interventions that have the potential to reduce exposure to biomass fuel during pregnancy and improve birth outcomes. International Centre for Diarrheal Disease Research, Bangladesh (icddr,b) therefore, designed a low-cost kitchen with an improved cookstove and examined the impact of this intervention on the birthweight of neonates.</p></div><div><h3>Methods</h3><p>icddr,b conducted a cluster-randomised controlled trial of a ‘low-cost kitchen with improved cookstove’ intervention among 1,267 pregnant women who used traditional cookstoves in a rural sub-district of Bangladesh. All participants were enrolled during the first trimester of pregnancy among 104 randomly selected clusters after obtaining informed consent. The model kitchens were installed in 628 participants' households of the intervention group, and 639 participants continued to use traditional cookstoves as the control group. The primary outcome was the proportion of LBW neonates between the intervention and control groups. The study also examined if the intervention would reduce CO exposure, measured by the differences in maternal blood carbon monoxide saturation (SpCO) levels and prevalence of LBW in neonates. We performed a generalized structural equation model for jointly assessing the simultaneous relationships of biomass fuel exposure to LBW of neonates and the relationships of LBW of neonates to maternal blood SpCO level. This trial was registered with <span>ClinicalTrials.gov</span><svg><path></path></svg> (<span>NCT02923882</span><svg><path></path></svg>).</p></div><div><h3>Findings</h3><p>We found that in the intervention group using ‘low-cost kitchen with improved cookstove’, the risk of LBW reduced by 37% (adjusted risk ratio: 0.63, 95% CI [0.45, 0.89]). Between the second and third trimester, the mean maternal blood SpCO level was significantly reduced from 10.4% to 8.9% (p-value &lt;0.01) in the intervention group but remained unchanged in the control group (11.6% and 11.5%). Of the total effects of the intervention on the risk of LBW, 48.3% was mediated through maternal blood SpCO level.</p></div><div><h3>Interpretation</h3><p>The risk of LBW among rural neonates was reduced in the intervention group using ‘low-cost kitchen with improved cookstove’, which may be attributed to the reduction in maternal blood SpCO level. Additional research is needed to identify other mechanisms through which biomass fuel exposure might lead to adverse pregnancy outcomes.</p></div><div><h3>Funding</h3><p>Grand Challenges Canada: Rising Stars in <span>Global Health Programme</span>.</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368223002020/pdfft?md5=8bb70572db37c8a5a9c1fb0f1bbf586a&pid=1-s2.0-S2772368223002020-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139392029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poor coverage of quality-adjusted antenatal care services: a population-level assessment by visit and source of antenatal care services in Bihar state of India 质量调整后产前保健服务覆盖率低:印度比哈尔邦按就诊和产前保健服务来源进行的人口评估
Pub Date : 2024-06-01 DOI: 10.1016/j.lansea.2023.100332
Rakhi Dandona , G Anil Kumar , Moutushi Majumder , Md Akbar , S Siva Prasad Dora , Lalit Dandona , ENHANCE 2020 team

Background

Despite the evidence on the poor quality of antenatal care (ANC) services, significant gap remains in the understanding of quality-adjusted coverage at the population-level for each ANC visit and by the source of ANC services, and in equity in this coverage.

Methods

All births between July 2020 and June 2021 were listed from 261,124 households (91.5% participation) representative of the Bihar state. Mothers of all stillbirths and neonatal deaths, and of 25% random sample of livebirths who survived the neonatal period provided data on each ANC visit up to a maximum of first 4 ANC visits, including the source of ANC services and the services received (weight measurement, blood pressure checked, abdomen checked, urine sample taken, and blood sample taken). An ANC visit was deemed of quality if all of these services were received in that visit. We report the coverage of quality-adjusted ANC services (Q-ANC) for ANC visits 1–4 disaggregated by source of ANC services and wealth index (WI). Weighted proportions are reported to take into account the sampling design.

Findings

A total of 30,412 births were reported by 29,517 women, and 7270 (82.1%) of the 8853 eligible women participated. Overall, 19,950 unique ANC visits from 6929 women were available for analysis, of which 41.7%, 13.8% and 44.5% were at Village Health and Nutrition Day (VNHD), public facility, and with a private provider, respectively. A total of 4409 (65.3%) of the 1st ANC visits were undertaken at VHND, with the proportion of private provider ANC visits increasing significantly from ANC visit 1 to ANC visit 4 (p < 0.001). Q-ANC coverage considering all ANC visits was 20.9% (95% CI 20.7–21.2); and was 0.9% (95% CI 0.8–1.0), 29.9% (95% CI 29.2–30.7) and 36.9% (95% CI 36.5–37.4) for ANC visits in VHND, public facilities, and with private provider, respectively. Q-ANC coverage in the public facility was significantly lower in the 4th ANC visit (25.1%; 95% CI 23.4–26.9) as compared with visits 1 to 3, whereas it was the highest for 1st ANC visit with private provider (50.2%; 95% CI 49.2–51.1) and then dropped for visits 2 to 4. Irrespective of the source of ANC services, Q-ANC coverage increased significantly with increasing WI quartile for ANC visits 1 and 2, with WI quartile 3 women having significantly less coverage for ANC visit 3 compared to the rest, and no significant difference seen in the coverage of ANC 4 visit. Varied pattern of Q-ANC coverage by WI for each ANC visit was seen for public facility and private provider visits.

Interpretation

With only 2 of 10 ANC visits deemed of adequate quality, sustainable delivery of quality ANC services are needed for every pregnant woman through-out the pregnancy irrespective of gestation period, number of ANC visit, and source of ANC services.

Funding

The funding was provided by the India office of the Bill

背景尽管有证据表明产前保健(ANC)服务的质量很差,但在了解每次产前保健就诊和产前保健服务来源的人口级质量调整覆盖率以及该覆盖率的公平性方面仍存在很大差距。方法列出了比哈尔邦具有代表性的 261,124 个家庭(91.5% 参与)在 2020 年 7 月至 2021 年 6 月期间的所有出生婴儿。所有死产和新生儿死亡的母亲以及 25% 的新生儿期存活活产婴儿的随机抽样母亲提供了每次产前检查的数据,最多不超过前 4 次产前检查,包括产前检查服务的来源和接受的服务(体重测量、血压检查、腹部检查、尿样采集和血样采集)。如果在产前检查中接受了所有这些服务,则该次产前检查被视为优质产前检查。我们按产前检查服务来源和财富指数 (WI) 分类,报告了产前检查 1-4 次的质量调整后产前检查服务 (Q-ANC) 覆盖率。考虑到抽样设计,报告了加权比例。研究结果29517 名妇女共报告了 30412 例分娩,8853 名符合条件的妇女中有 7270 人(82.1%)参与。共有 6929 名妇女的 19950 次产前检查可供分析,其中 41.7%、13.8% 和 44.5%的产前检查是在 "乡村健康与营养日"(VNHD)、公共设施和私营医疗机构进行的。共有 4409 次(65.3%)产前检查是在乡村保健和营养日进行的,从产前检查 1 次到产前检查 4 次,私人医疗机构产前检查的比例显著增加(p <0.001)。所有产前检查的 Q-ANC 覆盖率为 20.9% (95% CI 20.7-21.2);在 VHND、公共机构和私营医疗机构进行产前检查的 Q-ANC 覆盖率分别为 0.9% (95% CI 0.8-1.0)、29.9% (95% CI 29.2-30.7) 和 36.9% (95% CI 36.5-37.4)。与第 1 至第 3 次产前检查相比,公共机构第 4 次产前检查的 Q-ANC 覆盖率明显较低(25.1%;95% CI 23.4-26.9),而私人医疗机构第 1 次产前检查的 Q-ANC 覆盖率最高(50.2%;95% CI 49.2-51.1),第 2 至第 4 次产前检查的 Q-ANC 覆盖率则有所下降。无论产前保健服务的来源如何,Q-ANC 的覆盖率随着产前保健第 1 次和第 2 次 WI 四分位数的增加而显著增加,WI 四分位数第 3 位的妇女在产前保健第 3 次就诊时的覆盖率明显低于其他妇女,而在产前保健第 4 次就诊时的覆盖率则无显著差异。在公共机构和私人医疗机构的每次产前检查中,按 WI 四分位数划分的 Q-ANC 覆盖率呈现出不同的模式。解释由于 10 次产前检查中只有 2 次被认为是高质量的,因此无论妊娠期、产前检查次数和产前检查服务来源如何,都需要在整个孕期为每位孕妇持续提供高质量的产前检查服务。
{"title":"Poor coverage of quality-adjusted antenatal care services: a population-level assessment by visit and source of antenatal care services in Bihar state of India","authors":"Rakhi Dandona ,&nbsp;G Anil Kumar ,&nbsp;Moutushi Majumder ,&nbsp;Md Akbar ,&nbsp;S Siva Prasad Dora ,&nbsp;Lalit Dandona ,&nbsp;ENHANCE 2020 team","doi":"10.1016/j.lansea.2023.100332","DOIUrl":"10.1016/j.lansea.2023.100332","url":null,"abstract":"<div><h3>Background</h3><p>Despite the evidence on the poor quality of antenatal care (ANC) services, significant gap remains in the understanding of quality-adjusted coverage at the population-level for each ANC visit and by the source of ANC services, and in equity in this coverage.</p></div><div><h3>Methods</h3><p>All births between July 2020 and June 2021 were listed from 261,124 households (91.5% participation) representative of the Bihar state. Mothers of all stillbirths and neonatal deaths, and of 25% random sample of livebirths who survived the neonatal period provided data on each ANC visit up to a maximum of first 4 ANC visits, including the source of ANC services and the services received (weight measurement, blood pressure checked, abdomen checked, urine sample taken, and blood sample taken). An ANC visit was deemed of quality if all of these services were received in that visit. We report the coverage of quality-adjusted ANC services (Q-ANC) for ANC visits 1–4 disaggregated by source of ANC services and wealth index (WI). Weighted proportions are reported to take into account the sampling design.</p></div><div><h3>Findings</h3><p>A total of 30,412 births were reported by 29,517 women, and 7270 (82.1%) of the 8853 eligible women participated. Overall, 19,950 unique ANC visits from 6929 women were available for analysis, of which 41.7%, 13.8% and 44.5% were at Village Health and Nutrition Day (VNHD), public facility, and with a private provider, respectively. A total of 4409 (65.3%) of the 1st ANC visits were undertaken at VHND, with the proportion of private provider ANC visits increasing significantly from ANC visit 1 to ANC visit 4 (p &lt; 0.001). Q-ANC coverage considering all ANC visits was 20.9% (95% CI 20.7–21.2); and was 0.9% (95% CI 0.8–1.0), 29.9% (95% CI 29.2–30.7) and 36.9% (95% CI 36.5–37.4) for ANC visits in VHND, public facilities, and with private provider, respectively. Q-ANC coverage in the public facility was significantly lower in the 4th ANC visit (25.1%; 95% CI 23.4–26.9) as compared with visits 1 to 3, whereas it was the highest for 1st ANC visit with private provider (50.2%; 95% CI 49.2–51.1) and then dropped for visits 2 to 4. Irrespective of the source of ANC services, Q-ANC coverage increased significantly with increasing WI quartile for ANC visits 1 and 2, with WI quartile 3 women having significantly less coverage for ANC visit 3 compared to the rest, and no significant difference seen in the coverage of ANC 4 visit. Varied pattern of Q-ANC coverage by WI for each ANC visit was seen for public facility and private provider visits.</p></div><div><h3>Interpretation</h3><p>With only 2 of 10 ANC visits deemed of adequate quality, sustainable delivery of quality ANC services are needed for every pregnant woman through-out the pregnancy irrespective of gestation period, number of ANC visit, and source of ANC services.</p></div><div><h3>Funding</h3><p><span>The funding was provided by the India office of the Bill ","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368223001920/pdfft?md5=8428124c169ce17945297eda5c0bfa16&pid=1-s2.0-S2772368223001920-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139295140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequential levetiracetam and phenytoin in electroencephalographic neonatal seizures unresponsive to phenobarbital: a multicenter prospective observational study in India 顺序左乙拉西坦和苯妥英治疗对苯巴比妥无反应的新生儿癫痫发作:印度一项多中心前瞻性观察研究
Pub Date : 2024-06-01 DOI: 10.1016/j.lansea.2024.100371
Vaisakh Krishnan , Vidya Ujjanappa , Hemadri Vegda , Manjesh K. Annayappa , Pooja Wali , Sudhindrashayana Fattepur , Savitha Chandriah , Sahana Devadas , Mallesh Kariappa , Veluthedath Kuzhiyil Gireeshan , Ajithkumar Vellani Thamunni , Paolo Montaldo , Constance Burgod , Reema Garegrat , Pallavi Muraleedharan , Stuti Pant , Charles R. Newton , J Helen Cross , Paul Bassett , Seetha Shankaran , Ronit M. Pressler

Background

Although levetiracetam and phenytoin are widely used antiseizure medications (ASM) in neonates, their efficacy on seizure freedom is unclear. We evaluated electroencephalographic (EEG) seizure freedom following sequential levetiracetam and phenytoin in neonatal seizures unresponsive to phenobarbital.

Methods

We recruited neonates born ≥35 weeks and aged <72 h who had continued electrographic seizures despite phenobarbital, from three Indian hospitals, between 20 June 2020 and 31 July 2022. The neonates were treated with intravenous levetiracetam (20 mg/kg x 2 doses, second line) followed by phenytoin (20 mg/kg x 2 doses, third line) if seizures persisted. The primary outcome was complete seizure freedom, defined as an absence of seizures on EEG for at least 60 min within 40 min from the start of infusion.

Findings

Of the 206 neonates with continued seizures despite phenobarbital, 152 received levetiracetam with EEG. Of these one EEG was missing, 47 (31.1%) were in status epilepticus, and primary outcome data were available in 145. Seizure freedom occurred in 20 (13.8%; 95% CI 8.6%–20.5%) after levetiracetam; 16 (80.0%) responded to the first dose and 4 (20.0%) to the second dose. Of the 125 neonates with persisting seizures after levetiracetam, 114 received phenytoin under EEG monitoring. Of these, the primary outcome data were available in 104. Seizure freedom occurred in 59 (56.7%; 95% CI 46.7%–66.4%) neonates; 54 (91.5%) responded to the first dose and 5 (8.5%) to the second dose.

Interpretation

With the conventional doses, levetiracetam was associated with immediate EEG seizure cessation in only 14% of phenobarbital unresponsive neonatal seizures. Additional treatment with phenytoin along with levetiracetam attained seizure freedom in further 57%. Safety and efficacy of higher doses of levetiracetam should be evaluated in well-designed randomised controlled trials.

Funding

National Institute for Health and Care Research (NIHR) Research and Innovation for Global Health Transformation (NIHR200144).

背景虽然左乙拉西坦和苯妥英是新生儿中广泛使用的抗癫痫药物(ASM),但它们对癫痫发作自由度的疗效尚不明确。我们在 2020 年 6 月 20 日至 2022 年 7 月 31 日期间从印度三家医院招募了出生≥35 周、年龄为 72 h、服用苯巴比妥后仍有电图癫痫发作的新生儿,评估了他们在连续服用左乙拉西坦和苯妥英后的癫痫发作自由度。这些新生儿接受静脉注射左乙拉西坦(20 毫克/千克 x 2 次,二线治疗)治疗,如果癫痫持续发作,则接受苯妥英(20 毫克/千克 x 2 次,三线治疗)治疗。主要结果是完全无癫痫发作,即自输液开始 40 分钟内,脑电图至少 60 分钟无癫痫发作。其中1例脑电图缺失,47例(31.1%)处于癫痫状态,145例获得了主要结果数据。20例(13.8%;95% CI 8.6%-20.5%)新生儿在服用左乙拉西坦后摆脱了癫痫发作;16例(80.0%)对第一剂有反应,4例(20.0%)对第二剂有反应。在125名服用左乙拉西坦后癫痫持续发作的新生儿中,114名在脑电图监测下接受了苯妥英治疗。其中 104 例获得了主要结果数据。59例(56.7%;95% CI 46.7%-66.4%)新生儿无癫痫发作;54例(91.5%)对第一剂有反应,5例(8.5%)对第二剂有反应。在使用左乙拉西坦的同时辅以苯妥英治疗,又有57%的新生儿获得了癫痫发作自由。更高剂量左乙拉西坦的安全性和疗效应在精心设计的随机对照试验中进行评估。
{"title":"Sequential levetiracetam and phenytoin in electroencephalographic neonatal seizures unresponsive to phenobarbital: a multicenter prospective observational study in India","authors":"Vaisakh Krishnan ,&nbsp;Vidya Ujjanappa ,&nbsp;Hemadri Vegda ,&nbsp;Manjesh K. Annayappa ,&nbsp;Pooja Wali ,&nbsp;Sudhindrashayana Fattepur ,&nbsp;Savitha Chandriah ,&nbsp;Sahana Devadas ,&nbsp;Mallesh Kariappa ,&nbsp;Veluthedath Kuzhiyil Gireeshan ,&nbsp;Ajithkumar Vellani Thamunni ,&nbsp;Paolo Montaldo ,&nbsp;Constance Burgod ,&nbsp;Reema Garegrat ,&nbsp;Pallavi Muraleedharan ,&nbsp;Stuti Pant ,&nbsp;Charles R. Newton ,&nbsp;J Helen Cross ,&nbsp;Paul Bassett ,&nbsp;Seetha Shankaran ,&nbsp;Ronit M. Pressler","doi":"10.1016/j.lansea.2024.100371","DOIUrl":"10.1016/j.lansea.2024.100371","url":null,"abstract":"<div><h3>Background</h3><p>Although levetiracetam and phenytoin are widely used antiseizure medications (ASM) in neonates, their efficacy on seizure freedom is unclear. We evaluated electroencephalographic (EEG) seizure freedom following sequential levetiracetam and phenytoin in neonatal seizures unresponsive to phenobarbital.</p></div><div><h3>Methods</h3><p>We recruited neonates born ≥35 weeks and aged &lt;72 h who had continued electrographic seizures despite phenobarbital, from three Indian hospitals, between 20 June 2020 and 31 July 2022. The neonates were treated with intravenous levetiracetam (20 mg/kg x 2 doses, second line) followed by phenytoin (20 mg/kg x 2 doses, third line) if seizures persisted. The primary outcome was complete seizure freedom, defined as an absence of seizures on EEG for at least 60 min within 40 min from the start of infusion.</p></div><div><h3>Findings</h3><p>Of the 206 neonates with continued seizures despite phenobarbital, 152 received levetiracetam with EEG. Of these one EEG was missing, 47 (31.1%) were in status epilepticus, and primary outcome data were available in 145. Seizure freedom occurred in 20 (13.8%; 95% CI 8.6%–20.5%) after levetiracetam; 16 (80.0%) responded to the first dose and 4 (20.0%) to the second dose. Of the 125 neonates with persisting seizures after levetiracetam, 114 received phenytoin under EEG monitoring. Of these, the primary outcome data were available in 104. Seizure freedom occurred in 59 (56.7%; 95% CI 46.7%–66.4%) neonates; 54 (91.5%) responded to the first dose and 5 (8.5%) to the second dose.</p></div><div><h3>Interpretation</h3><p>With the conventional doses, levetiracetam was associated with immediate EEG seizure cessation in only 14% of phenobarbital unresponsive neonatal seizures. Additional treatment with phenytoin along with levetiracetam attained seizure freedom in further 57%. Safety and efficacy of higher doses of levetiracetam should be evaluated in well-designed randomised controlled trials.</p></div><div><h3>Funding</h3><p><span>National Institute for Health and Care Research</span> (NIHR) <span>Research and Innovation for Global Health Transformation</span> (<span>NIHR200144</span>).</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368224000209/pdfft?md5=12ca6c3c5fb5d57550eb85fb180818fa&pid=1-s2.0-S2772368224000209-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139827736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-discharge mortality among patients hospitalised with severe acute respiratory infection, Bangladesh, 2012–2019: a prospective observational study 2012-2019年孟加拉国严重急性呼吸道感染住院患者出院后死亡率:前瞻性观察研究
Pub Date : 2024-06-01 DOI: 10.1016/j.lansea.2024.100363
Md Ariful Islam , Md Zakiul Hassan , Mohammad Abdul Aleem , Zubair Akhtar , Sukanta Chowdhury , Md Kaousar Ahmmed , Mustafizur Rahman , Mohammed Ziaur Rahman , Syeda Mah-E-Muneer , M Salim Uzzaman , Tahmina Shirin , Meerjady Sabrina Flora , Mahmudur Rahman , William W. Davis , Eduardo Azziz-Baumgartner , A. Danielle Iuliano , Fahmida Chowdhury

Background

Enhancing outcomes post-hospitalisation requires an understanding of predictive factors for adverse events. This study aimed to estimate post-discharge mortality rates among patients with severe acute respiratory infection (SARI) in Bangladesh, identify associated factors, and document reported causes of death.

Methods

From January 2012 to December 2019, we conducted follow-up calls to patients or their families 30 days after discharge to assess the status of patients with SARI. Proportions of deaths within 30 days of discharge were estimated, and a comparative analysis of demographics, clinical characteristics, and influenza illness between decedents and survivors was performed using multivariable Cox regression models.

Findings

Among 23,360 patients with SARI (median age: 20 years, IQR: 1.5–48, 65% male), 351 (1.5%) died during hospitalisation. Of 23,009 patients alive at discharge, 20,044 (87%) were followed, with 633 (3.2%) deaths within 30 days of discharge. In children (<18 years), difficulty breathing (adjusted hazard ratio [aHR] 1.8; 95% CI 1.1–3.0), longer hospital stay (aHR 1.1; 95% CI 1.1–1.1), and heart diseases (aHR 8.5; 95% CI 3.2–23.1) were associated with higher post-discharge death risk. Among adults (≥18 years), difficulty breathing (aHR 2.3; 95% CI 1.7–3.0), chronic obstructive pulmonary disease (aHR 1.7; 95% CI 1.4–2.2), and intensive care unit admission (aHR 5.2; 95% CI 1.9–14.0) were linked to elevated post-discharge death risk. Influenza virus was detected in 13% (46/351) of in-hospital SARI deaths and 10% (65/633) of post-discharge SARI deaths.

Interpretation

Nearly one in twenty patients with SARI died during hospitalisation or within 1 month of discharge, with two-thirds of deaths occurring post-discharge. Seasonal influenza vaccination is recommended to mitigate influenza-associated mortality. To enhance post-discharge outcomes, hospitals should consider developing safe-discharge algorithms, reinforcing post-discharge care plans, and establishing outpatient monitoring for recently discharged patients.

Funding

Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA [U01GH002259].

背景提高住院后的治疗效果需要了解不良事件的预测因素。本研究旨在估算孟加拉国严重急性呼吸道感染(SARI)患者出院后的死亡率,确定相关因素,并记录报告的死亡原因。方法从 2012 年 1 月到 2019 年 12 月,我们对出院 30 天后的患者或其家属进行了随访,以评估 SARI 患者的状况。结果在 23360 名 SARI 患者(中位年龄:20 岁,IQR:1.5-48 岁,65% 为男性)中,有 351 人(1.5%)在住院期间死亡。在出院时存活的 23009 名患者中,20044 人(87%)接受了随访,其中 633 人(3.2%)在出院后 30 天内死亡。在儿童(18 岁)中,呼吸困难(调整后危险比 [aHR] 1.8;95% CI 1.1-3.0)、住院时间较长(aHR 1.1;95% CI 1.1-1.1)和心脏病(aHR 8.5;95% CI 3.2-23.1)与较高的出院后死亡风险有关。在成人(≥18 岁)中,呼吸困难(aHR 2.3;95% CI 1.7-3.0)、慢性阻塞性肺病(aHR 1.7;95% CI 1.4-2.2)和入住重症监护室(aHR 5.2;95% CI 1.9-14.0)与出院后死亡风险升高有关。在13%的院内SARI死亡病例(46/351)和10%的出院后SARI死亡病例(65/633)中检测到了流感病毒。建议接种季节性流感疫苗以降低流感相关死亡率。为提高出院后的治疗效果,医院应考虑制定安全出院算法、加强出院后护理计划,并对近期出院的患者进行门诊监测。
{"title":"Post-discharge mortality among patients hospitalised with severe acute respiratory infection, Bangladesh, 2012–2019: a prospective observational study","authors":"Md Ariful Islam ,&nbsp;Md Zakiul Hassan ,&nbsp;Mohammad Abdul Aleem ,&nbsp;Zubair Akhtar ,&nbsp;Sukanta Chowdhury ,&nbsp;Md Kaousar Ahmmed ,&nbsp;Mustafizur Rahman ,&nbsp;Mohammed Ziaur Rahman ,&nbsp;Syeda Mah-E-Muneer ,&nbsp;M Salim Uzzaman ,&nbsp;Tahmina Shirin ,&nbsp;Meerjady Sabrina Flora ,&nbsp;Mahmudur Rahman ,&nbsp;William W. Davis ,&nbsp;Eduardo Azziz-Baumgartner ,&nbsp;A. Danielle Iuliano ,&nbsp;Fahmida Chowdhury","doi":"10.1016/j.lansea.2024.100363","DOIUrl":"10.1016/j.lansea.2024.100363","url":null,"abstract":"<div><h3>Background</h3><p>Enhancing outcomes post-hospitalisation requires an understanding of predictive factors for adverse events. This study aimed to estimate post-discharge mortality rates among patients with severe acute respiratory infection (SARI) in Bangladesh, identify associated factors, and document reported causes of death.</p></div><div><h3>Methods</h3><p>From January 2012 to December 2019, we conducted follow-up calls to patients or their families 30 days after discharge to assess the status of patients with SARI. Proportions of deaths within 30 days of discharge were estimated, and a comparative analysis of demographics, clinical characteristics, and influenza illness between decedents and survivors was performed using multivariable Cox regression models.</p></div><div><h3>Findings</h3><p>Among 23,360 patients with SARI (median age: 20 years, IQR: 1.5–48, 65% male), 351 (1.5%) died during hospitalisation. Of 23,009 patients alive at discharge, 20,044 (87%) were followed, with 633 (3.2%) deaths within 30 days of discharge. In children (&lt;18 years), difficulty breathing (adjusted hazard ratio [aHR] 1.8; 95% CI 1.1–3.0), longer hospital stay (aHR 1.1; 95% CI 1.1–1.1), and heart diseases (aHR 8.5; 95% CI 3.2–23.1) were associated with higher post-discharge death risk. Among adults (≥18 years), difficulty breathing (aHR 2.3; 95% CI 1.7–3.0), chronic obstructive pulmonary disease (aHR 1.7; 95% CI 1.4–2.2), and intensive care unit admission (aHR 5.2; 95% CI 1.9–14.0) were linked to elevated post-discharge death risk. Influenza virus was detected in 13% (46/351) of in-hospital SARI deaths and 10% (65/633) of post-discharge SARI deaths.</p></div><div><h3>Interpretation</h3><p>Nearly one in twenty patients with SARI died during hospitalisation or within 1 month of discharge, with two-thirds of deaths occurring post-discharge. Seasonal influenza vaccination is recommended to mitigate influenza-associated mortality. To enhance post-discharge outcomes, hospitals should consider developing safe-discharge algorithms, reinforcing post-discharge care plans, and establishing outpatient monitoring for recently discharged patients.</p></div><div><h3>Funding</h3><p><span>Centers for Disease Control and Prevention</span> (CDC), Atlanta, Georgia, USA [<span>U01GH002259</span>].</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772368224000131/pdfft?md5=9b3d7a808a749885a922aa911eb7a4fd&pid=1-s2.0-S2772368224000131-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140469633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet regional health. Southeast Asia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1